| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of PHLDA2 mRNA" | 20453058 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PHLDA2 mRNA" | 25614096 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA" | 19167446 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of PHLDA2 mRNA" | 21346803 |
| C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of PHLDA2 mRNA | 16788091 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of PHLDA2 mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C020738 | 9,10-dihydro-9,10-dihydroxybenzo(a)pyrene | "9,10-dihydro-9,10-dihydroxybenzo(a)pyrene results in increased expression of PHLDA2 mRNA" | 26238291 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of PHLDA2 mRNA | 25064622 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of PHLDA2 mRNA | 26690555 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PHLDA2 mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of PHLDA2 mRNA | 17562736 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of PHLDA2 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of PHLDA2 mRNA | 21641981|2210060 |
| C068073 | Am 580 | Am 580 results in decreased expression of PHLDA2 mRNA | 16982809 |
| D000638 | Amiodarone | Amiodarone affects the expression of PHLDA2 mRNA | 25064622 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of PHLDA2 mRNA | 24449571 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of PHLDA2 mRNA | 15761015 |
| D001205 | Ascorbic Acid | [Quercetin co-treated with Ascorbic Acid] results in increased expression of PHLDA2 mRNA | 17639512 |
| D001379 | Azathioprine | Azathioprine results in increased expression of PHLDA2 mRNA | 22623647 |
| D001507 | Beclomethasone | Beclomethasone results in increased expression of PHLDA2 mRNA | 23656298 |
| C487081 | belinostat | belinostat results in increased expression of PHLDA2 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PHLDA2 mRNA | 20106945|2163298 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PHLDA2 mRNA" | 19150397|2623829 |
| D004958 | Estradiol | Estradiol affects the expression of PHLDA2 mRNA | 22574217 |
| D004958 | Estradiol | Estradiol results in increased expression of PHLDA2 mRNA | 23019147 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PHLDA2 mRNA | 26063408 |
| C006780 | bisphenol A | bisphenol A affects the expression of PHLDA2 mRNA | 25181051 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA | 23410634 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA | 15336504 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of PHLDA2 mRNA | 26079696 |
| C584509 | C646 compound | C646 compound results in increased expression of PHLDA2 mRNA | 26191083 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of PHLDA2 mRNA | 25979313 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of PHLDA2 mRNA | 26272509 |
| D002746 | Chlorpromazine | Chlorpromazine affects the expression of PHLDA2 mRNA | 25064622 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of PHLDA2 mRNA | 21356183 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of PHLDA2 mRNA | 28472532 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of PHLDA2 mRNA | 19524605 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of PHLDA2 mRNA | 24612858 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of PHLDA2 mRNA | 19320972 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of PHLDA2 mRNA | 19376846 |
| D003300 | Copper | [Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA | 24690739 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of PHLDA2 mRNA | 19549813 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA" | 19167446 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of PHLDA2 mRNA | 17403535 |
| D016572 | Cyclosporine | Cyclosporine affects the expression of PHLDA2 mRNA | 25064622 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of PHLDA2 mRNA | 20106945|2163298 |
| C089595 | cylindrospermopsin | cylindrospermopsin results in increased expression of PHLDA2 mRNA | 24921660 |
| C014347 | decitabine | decitabine results in increased expression of PHLDA2 mRNA | 21856257 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA | 28628672 |
| D003976 | Diazinon | Diazinon results in increased methylation of PHLDA2 gene | 22964155 |
| D002945 | Cisplatin | Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA] | 21858171 |
| D002945 | Cisplatin | PHLDA2 results in increased susceptibility to Cisplatin | 22021909 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of PHLDA2 mRNA | 21527772 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PHLDA2 mRNA | 24535843 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of PHLDA2 mRNA | 17547211 |
| C051904 | dinophysistoxin 1 | dinophysistoxin 1 results in increased expression of PHLDA2 mRNA | 28939011 |
| D004221 | Disulfiram | [Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA | 24690739 |
| C118739 | entinostat | entinostat results in increased expression of PHLDA2 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| D015251 | Epirubicin | PHLDA2 results in increased susceptibility to Epirubicin | 22021909 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PHLDA2 mRNA | 22079256 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of PHLDA2 mRNA | 25064622 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHLDA2 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of PHLDA2 mRNA | 23550701 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of PHLDA2 mRNA | 23649840 |
| C039281 | furan | furan results in increased expression of PHLDA2 mRNA | 25539665|2619464 |
| C419708 | gefitinib | PHLDA2 protein affects the susceptibility to gefitinib | 15496427 |
| D019833 | Genistein | Genistein results in increased expression of PHLDA2 mRNA | 15256057|2301914 |
| C412815 | GW 4064 | GW 4064 results in increased expression of PHLDA2 mRNA | 26655953 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of PHLDA2 mRNA | 20044591|2341063 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA | 28628672 |
| C051890 | irinotecan | irinotecan results in increased expression of PHLDA2 mRNA | 20185912 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA | 28628672 |
| C533894 | LG 100815 | LG 100815 results in decreased expression of PHLDA2 mRNA | 16951191 |
| D015122 | Mercaptopurine | Mercaptopurine results in decreased expression of PHLDA2 mRNA | 23358152 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of PHLDA2 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of PHLDA2 mRNA | 23179753|2627250 |
| C004925 | methylmercuric chloride | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C568376 | MT19c compound | MT19c compound results in decreased expression of PHLDA2 mRNA | 21781307 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of PHLDA2 mRNA | 15674844 |
| C022838 | nickel chloride | nickel chloride results in increased expression of PHLDA2 mRNA | 24612858 |
| C022838 | nickel chloride | nickel chloride results in increased expression of PHLDA2 mRNA | 17547211 |
| C062198 | octa-2,4,6-trienoic acid | "octa-2,4,6-trienoic acid results in decreased expression of PHLDA2 mRNA" | 16951191 |
| C507134 | ON 01910 | ON 01910 results in increased expression of PHLDA2 mRNA | 22351695 |
| D009966 | Orphenadrine | Orphenadrine affects the expression of PHLDA2 mRNA | 23665939 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of PHLDA2 mRNA | 26272509 |
| D010269 | Paraquat | Paraquat affects the expression of PHLDA2 mRNA | 25064622 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of PHLDA2 mRNA | 15046786 |
| C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of PHLDA2 mRNA | 18593933 |
| C046012 | pentanal | pentanal results in increased expression of PHLDA2 mRNA | 26079696 |
| C027579 | periodate-oxidized adenosine | periodate-oxidized adenosine affects the expression of PHLDA2 mRNA | 17097637 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PHLDA2 mRNA | 24535843 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PHLDA2 mRNA] | 19482888 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of PHLDA2 mRNA | 19482888 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of PHLDA2 mRNA | 26272509 |
| D010894 | Piroxicam | Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA] | 21858171 |
| D010894 | Piroxicam | Piroxicam results in decreased expression of PHLDA2 mRNA | 21858171 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of PHLDA2 mRNA | 23557933 |
| D010938 | Plant Oils | Plant Oils results in increased expression of PHLDA2 mRNA | 23370395 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PHLDA2 mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in increased expression of PHLDA2 mRNA | 22079256 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of PHLDA2 protein | 23718831 |
| D011374 | Progesterone | Progesterone results in increased expression of PHLDA2 mRNA | 18037150 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of PHLDA2 mRNA | 24780913 |
| D011794 | Quercetin | [Quercetin co-treated with Ascorbic Acid] results in increased expression of PHLDA2 mRNA | 17639512 |
| D011794 | Quercetin | Quercetin results in increased expression of PHLDA2 mRNA | 21632981 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of PHLDA2 mRNA | 20436886 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of PHLDA2 mRNA | 16982809 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of PHLDA2 mRNA | 25895662 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of PHLDA2 mRNA | 21281968 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of PHLDA2 mRNA | 24612858 |
| D012999 | Soman | Soman results in decreased expression of PHLDA2 mRNA | 19281266 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PHLDA2 mRNA | 16714409 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PHLDA2 mRNA | 26238291 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHLDA2 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in decreased expression of PHLDA2 mRNA | 25975270 |
| D013752 | Tetracycline | Tetracycline affects the expression of PHLDA2 mRNA | 25064622 |
| D013853 | Thioacetamide | Thioacetamide affects the expression of PHLDA2 mRNA | 25064622 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of PHLDA2 mRNA | 23411599 |
| D019772 | Topotecan | Topotecan results in increased expression of PHLDA2 mRNA | 25729387 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PHLDA2 mRNA | 23830798 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PHLDA2 mRNA | 16788091 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of PHLDA2 mRNA | 24935251|2627250 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of PHLDA2 mRNA" | 26179874 |
| C057693 | troglitazone | troglitazone results in increased expression of PHLDA2 mRNA | 19140230 |
| D014520 | Urethane | Urethane results in increased expression of PHLDA2 mRNA | 28818685 |
| C406224 | valdecoxib | valdecoxib results in increased expression of PHLDA2 mRNA | 24136188 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of PHLDA2 mRNA | 25064622 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of PHLDA2 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PHLDA2 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of PHLDA2 gene | 29154799 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of PHLDA2 mRNA | 15046786 |
| D024483 | Vitamin K 3 | Vitamin K 3 affects the expression of PHLDA2 mRNA | 20044591|2341063 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of PHLDA2 mRNA | 26272509 |
| D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of PHLDA2 mRNA | 18593933 |